The cholesterol conundrum

Journal of the American Geriatrics Society

Volumn 59, Issue 10, 2011, Pages 1955-1956

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EDITORIAL; ELDERLY CARE; HUMAN; MORTALITY; MYALGIA; MYOPATHY;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE;

EID: 80054806209     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03594.x     Document Type: Editorial

References (19)

1. Kaiser FE, Morley JE,. Cholesterol can be lowered in older persons. Should we care? J Am Geriatr Soc 1990; 38: 84-85.
2. Newson RS, Felix JF, Herringa J, et al. Association between serum cholesterol and non-cardiovascular mortality in older age. J Am Geriatr Soc 2011; 59: 1779-1785.
3. Morley JE,. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007; 13: 3637-3647.
4. Rizzo M, Berneis K, Corrado E, et al. The significance of low-density-lipoproteins size in vascular diseases. Int Angiol 2006; 25: 4-9.
5. Barzilai N, Atzmon G, Schechter C, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003; 290: 2030-2040.
6. Heijmans BT, Beekman M, Houwing-Duistermaat JJ, et al. Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med 2006; 3: e495.
7. Ranieri P, Rozzini R, Franzoni S, et al. Serum cholesterol levels as a measure of frailty in elderly patients. Exp Aging Res 1998; 24: 169-179.
8. Morley JE, Banks WA,. Lipids and cognition. J Alzheimers Dis 2010; 20: 737-747.
9. Roberts CGP, Guallar E, Rodriguez A,. Efficacy and safety of statin monotherapy in older adults: A meta-analysis. J Gerontrol A Biol Sci Med Sci 2007; 62A: 879-887.
10. Afilalo J, Duque G, Steele R, et al. Statins for secondary prevention in elderly patients: A hierarchical Bayesian meta-analysis. J Am Coll Cardiol 2008; 51: 37-45.
11. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 2002; 360: 1623-1630.
12. Kuoppala J, Lammingpaa A, Pukkala E,. Statins and cancer: A systematic review and meta-analysis. Eur J Cancer 2008; 44: 2122-2132.
13. Allen Maycock CA, Muhlestein JB, Horne BD, et al. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 2002; 40: 1777-1785.
14. Morales K, Wittink M, Datto C, et al. Simvastatin causes changes in affective processes in elderly volunteers. J Am Geriatr Soc 2006; 54: 70-76.
15. Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009; 153: 11-16.
16. Lee JS, Kwok T, Leung PC, et al. Medical illnesses are more important than medications as risk factors of falls in older community dwellers? A cross-sectional study. Age Ageing 2006; 35: 246-251.
17. Mills EJ, Wu P, Chong G, et al. Efficacy and safety of statin treatment for cardiovascular disease: A network meta-analysis of 170255 patients from 76 randomized trials. Q J Med 2011; 104: 109-124.
18. Fitzgerald SP, Bean NG,. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010; 11: 475-484.
19. Tolson D, Rolland Y, Andrieu S, et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011; 12: 184-189.